Aker BioMarine scientists and members of the company's Science Advisory Board met to discuss future studies and krill sustainability.
Reporting on a recent meeting between its R&D scientists and its Science Advisory Board, Aker BioMarine (Oslo, Norway) says it is planning a future study on krill for joint health and inflammation for later this year. The krill ingredients supplier plans to incorporate krill oils and powders in the human study.
Sustainability of krill resources was also discussed at the recent meeting. Researchers concluded that there is still no sign of krill catch affecting any populations of krill predators.
Glanbia Nutritionals announces launch of high potency collagen tripeptide ingredient
June 4th 2024According to the company, Collamet is absorbed four times faster and has 10 times the efficacy of traditional collagen peptides. The ingredient will initially be offered in the North American market.